Molecular Diagnosis of Head and Neck Cancer
Authors:
- 1 January 2000
- book chapter
- Published by Springer Nature
- Vol. 157, 90-106
Abstract
Patients with advanced stages of head and neck cancer frequently develop locoregional recurrence as well as distant metastases. These data indicate that traditional diagnostic methods such as histopathology and radiology are not sensitive enough to detect the small numbers of tumor cells which are left behind, defined as minimal residual disease (MRD). Sensitive diagnostic assays based on molecular markers appear to be powerful tools to improve the staging of these patients. At the DNA level, tumor-specific p53 mutations seem to have great potential for the detection of “occult” tumor cells at surgical margins and lymph nodes. At the RNA level HNSCC associated antigens like the E48 antigen, allow the detection of rare HNSCC cells in blood and bone marrow and, it is hoped, also in lymph nodes and lymph node aspirates. However, the molecular assays which are used to detect MRD are subject to certain (technical) problems which affect their sensitivity and specificity. In this paper we will present examples of molecular assays such as the plaque assay using p53 mutations and the E48 RT-PCR, and show their use for MRD detection in cervical lymph nodes. In addition, we will discuss the problems and pitfalls associated with these sensitive techniques.Keywords
This publication has 45 references indexed in Scilit:
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumoursNuclear Medicine Communications, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck regionInternational Journal of Oral and Maxillofacial Surgery, 1995
- Expression of the MAGE gene family in human head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1995
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- Genes Coding for Tumor Antigens Recognized by Human Cytolytic T LymphocytesJournal of Immunotherapy, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992